Results

1–10 of 25 results for Risk Management

Real-World Intraocular Pressure (IOP) and Glaucoma Outcomes From Intravitreal Treatments Based on Injection Volume
Deepak Sambhara, MD
Annual Meeting Talks
2025
Early Vitrectomy vs Intravitreal Antibiotics Only for Postinjection Endophthalmitis: An IRIS (Intelligent Research in Sight) Registry Report
Andrew C Lin, MD
Annual Meeting Talks
2025
The Use of Incorrect Intraocular Gas Tamponades During Vitreoretinal Surgery
Gaurav K. Shah, MD
Annual Meeting Talks
2025
Expert Panel: Sustainability
Geoffrey G. Emerson, MD, PhD, FASRS
Jacob D. Grodsky, MD
David R Anderson, MD, PharmD
Scott M McClintic, MD
Annual Meeting Talks
2024
Short-term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits
William E. Smiddy, MD
Annual Meeting Talks
2021
Results of One Year of Contact Precautions During COVID-19: Universal Gloving, Masking of Patients and Double Masking of Staff in a Retina Practice
Abdhish R. Bhavsar, MD FASRS
Annual Meeting Talks
2021
A Novel Smartphone APP for Risk Estimation of Gas Volume Expansion and Intraocular Pressure Elevation in Patients With Intravitreous Gas/Air Tamponade
Zhaotian Zhang, MD
On Demand Cases, Courses, and Papers
2020
Reduced Incidence of Post-Injection Endophthalmitis With Pre-filled Syringes
Daniel B. Roth, MD
On Demand Cases, Courses, and Papers
2020
Analysis of Emergent Non-Hospital Based Retina Consultation Requests in an Academic Non-Hospital Associated Retina Practice
Barton L Blackorby, MD
Annual Meeting Talks
2020
PREVALENCE AND RISK FACTORS OF OCULOCARDIAC REFLEX IN VITRECTOMY WITH RETROBULBAR ANESTHESIA: A 6 YEAR RETROSPECTIVE CHART REVIEW
Narciso F. Atienza, MD, MBA, FASRS, FVRSP, FPCS, FPAO.
On Demand Cases, Courses, and Papers
2019